 Jonathan Boyd
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytokines | 5 | 2020 | 2045 | 1.270 |
Why?
| | Rotenone | 5 | 2016 | 20 | 1.140 |
Why?
| | Gloves, Protective | 1 | 2026 | 3 | 0.960 |
Why?
| | Aircraft | 1 | 2026 | 23 | 0.940 |
Why?
| | Femoral Fractures | 3 | 2017 | 84 | 0.940 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2024 | 161 | 0.900 |
Why?
| | Cold Temperature | 1 | 2026 | 208 | 0.840 |
Why?
| | Enzyme Inhibitors | 4 | 2016 | 820 | 0.780 |
Why?
| | Chlorpyrifos | 1 | 2021 | 7 | 0.690 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 306 | 0.680 |
Why?
| | Pesticides | 1 | 2021 | 63 | 0.660 |
Why?
| | Wound Healing | 3 | 2018 | 352 | 0.640 |
Why?
| | Corticosterone | 1 | 2021 | 242 | 0.630 |
Why?
| | Interleukin-4 | 1 | 2020 | 206 | 0.620 |
Why?
| | Phosphorylation | 7 | 2021 | 1704 | 0.600 |
Why?
| | Toxicology | 1 | 2020 | 49 | 0.590 |
Why?
| | Biological Assay | 1 | 2020 | 128 | 0.590 |
Why?
| | Drug Overdose | 1 | 2024 | 371 | 0.580 |
Why?
| | Perfusion Imaging | 1 | 2018 | 65 | 0.550 |
Why?
| | Joint Dislocations | 1 | 2018 | 60 | 0.540 |
Why?
| | Angiography | 1 | 2018 | 208 | 0.530 |
Why?
| | Xenobiotics | 2 | 2020 | 31 | 0.520 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2021 | 287 | 0.520 |
Why?
| | Intracellular Space | 1 | 2017 | 64 | 0.520 |
Why?
| | Phenyl Ethers | 1 | 2017 | 5 | 0.520 |
Why?
| | Extracellular Space | 1 | 2017 | 119 | 0.510 |
Why?
| | Cyclohexanes | 1 | 2017 | 23 | 0.510 |
Why?
| | Propylene Glycols | 1 | 2017 | 28 | 0.510 |
Why?
| | Electronic Nicotine Delivery Systems | 3 | 2025 | 108 | 0.500 |
Why?
| | Hep G2 Cells | 5 | 2014 | 75 | 0.480 |
Why?
| | Graft Survival | 1 | 2018 | 510 | 0.470 |
Why?
| | Toxicity Tests | 2 | 2014 | 53 | 0.470 |
Why?
| | Spatio-Temporal Analysis | 1 | 2015 | 39 | 0.460 |
Why?
| | Electron Transport Complex I | 1 | 2016 | 42 | 0.460 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 372 | 0.450 |
Why?
| | Signal Transduction | 4 | 2017 | 5185 | 0.440 |
Why?
| | Mitochondria | 2 | 2020 | 984 | 0.440 |
Why?
| | Drug Discovery | 1 | 2016 | 153 | 0.430 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2016 | 176 | 0.430 |
Why?
| | Femur | 1 | 2015 | 251 | 0.400 |
Why?
| | Water Pollutants, Chemical | 1 | 2017 | 229 | 0.400 |
Why?
| | Energy Metabolism | 1 | 2020 | 927 | 0.400 |
Why?
| | Fentanyl | 2 | 2026 | 127 | 0.400 |
Why?
| | Vaping | 3 | 2025 | 66 | 0.390 |
Why?
| | Phosphoproteins | 1 | 2015 | 339 | 0.390 |
Why?
| | Tissue Distribution | 1 | 2014 | 335 | 0.390 |
Why?
| | Complex Mixtures | 1 | 2012 | 12 | 0.380 |
Why?
| | Cell Death | 1 | 2014 | 382 | 0.370 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 265 | 0.360 |
Why?
| | Antioxidants | 1 | 2016 | 546 | 0.360 |
Why?
| | Plant Extracts | 1 | 2013 | 188 | 0.350 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 35 | 0.340 |
Why?
| | Lung Injury | 2 | 2026 | 236 | 0.320 |
Why?
| | Animals | 14 | 2026 | 37948 | 0.310 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 466 | 0.310 |
Why?
| | Chronic Disease | 1 | 2016 | 1810 | 0.300 |
Why?
| | Rats, Sprague-Dawley | 5 | 2025 | 2521 | 0.300 |
Why?
| | Rats | 6 | 2025 | 5570 | 0.300 |
Why?
| | Indocyanine Green | 2 | 2020 | 42 | 0.300 |
Why?
| | Hypogastric Plexus | 1 | 2009 | 1 | 0.290 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 2019 | 0.290 |
Why?
| | Cervical Ripening | 1 | 2009 | 9 | 0.290 |
Why?
| | Wounds and Injuries | 1 | 2017 | 960 | 0.290 |
Why?
| | Brain | 1 | 2021 | 2934 | 0.280 |
Why?
| | Cervix Uteri | 1 | 2009 | 50 | 0.280 |
Why?
| | Cell Survival | 3 | 2020 | 1092 | 0.280 |
Why?
| | Parturition | 1 | 2009 | 68 | 0.280 |
Why?
| | Biomarkers | 2 | 2020 | 4261 | 0.260 |
Why?
| | Analgesics, Opioid | 2 | 2026 | 1142 | 0.240 |
Why?
| | Membrane Proteins | 1 | 2012 | 1159 | 0.240 |
Why?
| | Apoptosis | 3 | 2026 | 2397 | 0.240 |
Why?
| | Deoxyglucose | 2 | 2020 | 49 | 0.240 |
Why?
| | Aerospace Medicine | 1 | 2026 | 32 | 0.230 |
Why?
| | Skin Temperature | 1 | 2026 | 36 | 0.230 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1788 | 0.220 |
Why?
| | Fingers | 1 | 2026 | 107 | 0.220 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 56 | 0.220 |
Why?
| | Mast Cells | 1 | 2026 | 148 | 0.210 |
Why?
| | Maternal Health | 1 | 2025 | 49 | 0.210 |
Why?
| | Adenosine Triphosphate | 2 | 2020 | 501 | 0.210 |
Why?
| | Adoptive Transfer | 1 | 2024 | 197 | 0.210 |
Why?
| | Titanium | 1 | 2024 | 76 | 0.200 |
Why?
| | Oxygen Consumption | 2 | 2020 | 717 | 0.200 |
Why?
| | Nicotinic Agonists | 1 | 2025 | 138 | 0.200 |
Why?
| | Prostheses and Implants | 1 | 2024 | 141 | 0.190 |
Why?
| | Acute Lung Injury | 1 | 2026 | 301 | 0.190 |
Why?
| | Osteogenesis | 1 | 2024 | 207 | 0.190 |
Why?
| | Dendritic Cells | 1 | 2026 | 498 | 0.180 |
Why?
| | Cerebral Cortex | 1 | 2026 | 470 | 0.180 |
Why?
| | Pneumonia | 2 | 2026 | 629 | 0.180 |
Why?
| | Structure-Activity Relationship | 2 | 2014 | 564 | 0.180 |
Why?
| | Imidazoles | 2 | 2014 | 246 | 0.180 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 343 | 0.180 |
Why?
| | Postpartum Period | 1 | 2025 | 368 | 0.170 |
Why?
| | Vasodilation | 1 | 2025 | 520 | 0.170 |
Why?
| | Cerebrovascular Disorders | 1 | 2022 | 106 | 0.170 |
Why?
| | Humans | 14 | 2026 | 144671 | 0.170 |
Why?
| | Rodentia | 1 | 2020 | 62 | 0.160 |
Why?
| | Mice | 5 | 2026 | 18261 | 0.160 |
Why?
| | 4-Chloro-7-nitrobenzofurazan | 1 | 2020 | 3 | 0.160 |
Why?
| | Interleukin-12 | 1 | 2020 | 117 | 0.160 |
Why?
| | NADP | 1 | 2020 | 53 | 0.150 |
Why?
| | Interleukin-13 | 1 | 2020 | 144 | 0.150 |
Why?
| | NAD | 1 | 2020 | 82 | 0.150 |
Why?
| | Pyridines | 2 | 2014 | 603 | 0.150 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 117 | 0.140 |
Why?
| | External Fixators | 1 | 2018 | 21 | 0.140 |
Why?
| | Workflow | 1 | 2020 | 182 | 0.140 |
Why?
| | Debridement | 1 | 2018 | 85 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 641 | 0.140 |
Why?
| | Skin Transplantation | 1 | 2018 | 85 | 0.140 |
Why?
| | In Vitro Techniques | 1 | 2020 | 1046 | 0.140 |
Why?
| | Elbow Joint | 1 | 2018 | 73 | 0.130 |
Why?
| | Mice, Inbred C57BL | 3 | 2026 | 5967 | 0.130 |
Why?
| | West Virginia | 1 | 2017 | 9 | 0.130 |
Why?
| | Male | 7 | 2026 | 72431 | 0.130 |
Why?
| | Rivers | 1 | 2017 | 68 | 0.120 |
Why?
| | Caspase 3 | 1 | 2017 | 234 | 0.120 |
Why?
| | Macrophages | 1 | 2024 | 1496 | 0.120 |
Why?
| | Muscles | 1 | 2017 | 332 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 770 | 0.120 |
Why?
| | Knee Joint | 1 | 2020 | 426 | 0.120 |
Why?
| | Parkinson Disease, Secondary | 1 | 2016 | 8 | 0.120 |
Why?
| | Plants, Medicinal | 1 | 2016 | 23 | 0.120 |
Why?
| | Lung | 2 | 2026 | 4089 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2020 | 1207 | 0.120 |
Why?
| | Rural Population | 1 | 2021 | 657 | 0.120 |
Why?
| | Phytotherapy | 1 | 2016 | 74 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4539 | 0.110 |
Why?
| | Prognosis | 1 | 2024 | 4312 | 0.110 |
Why?
| | Molecular Structure | 1 | 2016 | 495 | 0.110 |
Why?
| | HEK293 Cells | 1 | 2017 | 743 | 0.100 |
Why?
| | Environmental Monitoring | 1 | 2017 | 374 | 0.100 |
Why?
| | Staurosporine | 1 | 2012 | 22 | 0.090 |
Why?
| | Mitochondrial Membranes | 1 | 2012 | 40 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2014 | 516 | 0.090 |
Why?
| | Potassium Cyanide | 1 | 2012 | 24 | 0.090 |
Why?
| | Permeability | 1 | 2012 | 169 | 0.090 |
Why?
| | Tumor Cells, Cultured | 1 | 2014 | 881 | 0.090 |
Why?
| | Cell Line | 1 | 2017 | 2821 | 0.090 |
Why?
| | Young Adult | 2 | 2026 | 14122 | 0.080 |
Why?
| | Pyridazines | 1 | 2011 | 57 | 0.080 |
Why?
| | Polyps | 1 | 2010 | 14 | 0.080 |
Why?
| | Vocal Cord Paralysis | 1 | 2010 | 27 | 0.080 |
Why?
| | Models, Chemical | 1 | 2011 | 264 | 0.080 |
Why?
| | Durapatite | 1 | 2010 | 37 | 0.080 |
Why?
| | Laryngeal Diseases | 1 | 2010 | 31 | 0.080 |
Why?
| | Foreign-Body Reaction | 1 | 2010 | 36 | 0.080 |
Why?
| | Denervation | 1 | 2009 | 27 | 0.070 |
Why?
| | Rats, Long-Evans | 1 | 2009 | 127 | 0.070 |
Why?
| | Oxygen | 1 | 2013 | 984 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2014 | 971 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 2117 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2014 | 1338 | 0.060 |
Why?
| | Time Factors | 1 | 2017 | 7140 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8284 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2010 | 436 | 0.060 |
Why?
| | Necrosis | 1 | 2026 | 243 | 0.050 |
Why?
| | Sirtuin 1 | 1 | 2025 | 34 | 0.050 |
Why?
| | Adult | 2 | 2026 | 40489 | 0.050 |
Why?
| | Implants, Experimental | 1 | 2024 | 21 | 0.050 |
Why?
| | Inhalation Exposure | 1 | 2025 | 103 | 0.050 |
Why?
| | Pregnancy | 2 | 2025 | 7122 | 0.050 |
Why?
| | Cellular Microenvironment | 1 | 2024 | 93 | 0.050 |
Why?
| | Immunomodulation | 1 | 2024 | 98 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2018 | 11735 | 0.050 |
Why?
| | Maternal Exposure | 1 | 2025 | 185 | 0.050 |
Why?
| | Female | 5 | 2025 | 78304 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 10796 | 0.040 |
Why?
| | Gestational Age | 1 | 2025 | 980 | 0.040 |
Why?
| | Appalachian Region | 1 | 2021 | 17 | 0.040 |
Why?
| | Myocardium | 1 | 2026 | 928 | 0.040 |
Why?
| | MicroRNAs | 1 | 2026 | 689 | 0.040 |
Why?
| | Nicotine | 1 | 2022 | 334 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2026 | 3109 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2025 | 864 | 0.040 |
Why?
| | Inflammation | 1 | 2024 | 2870 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2010 | 91 | 0.020 |
Why?
| | Injections | 1 | 2010 | 197 | 0.020 |
Why?
| | Laryngoscopy | 1 | 2010 | 119 | 0.020 |
Why?
| | Biopsy | 1 | 2010 | 1079 | 0.010 |
Why?
| | Middle Aged | 2 | 2021 | 35971 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22409 | 0.010 |
Why?
| | Aged | 1 | 2021 | 25955 | 0.010 |
Why?
|
|
Boyd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|